Add BrightSurf on Google Email

Dr. Petter Bjornstad named Senior Vice Chancellor and Executive Director of LSU’s Pennington Biomedical Research Center

Dr. Petter Bjornstad will lead Pennington Biomedical Research Center in advancing research in metabolic disease, with a focus on improving the health and well-being of Louisiana residents. He brings exceptional expertise in diabetes and kidney disease, with a vision to translate world-class science into better health outcomes.

Heart drug combo reduces kidney damage in septic shock surgery, major trial finds

A new study has found that combining medications dobutamine and norepinephrine during septic shock surgery can significantly lower the risk of acute kidney injury. The trial, which tracked 584 adult patients, showed that the drug combination cut the risk of severe kidney damage in half, reducing moderate to severe kidney injuries.

SourceUniversity of Southampton·JournalJournal of the American Medical Association·TypeRandomized controlled/clinical trial·DateOct 27, 2026

National study finds decline in drug use-associated heart infections but growing share involve stimulants

Hospitalizations for drug use-associated heart infections have declined by 18% from 2020 to 2022, primarily due to a decrease in opioid cases. Stimulants, such as methamphetamine and cocaine, are increasingly involved in these infections, particularly in the Western US, highlighting the need for improved treatment options.

SourceUniversity of Colorado Anschutz·JournalClinical Infectious Diseases·DateOct 27, 2026

Machine learning spots hidden risk of functional decline after heart failure

Researchers developed a machine learning model that predicts functional decline after heart failure, identifying patients at risk of losing independence despite surviving hospitalization. The model outperformed traditional prognostic approaches, highlighting the importance of physical function at discharge.

SourceJuntendo University Research Promotion Center·JournalJournal of Cardiac Failure·TypeData/statistical analysis·DateOct 20, 2026

Study offers insights on how heart valves last so long

Researchers found that applying biomechanical tension to heart valves every time they beat helps protect collagen from breaking down, explaining why leaflets remain sturdy for decades. Increasing strain while preserving the natural strain ratio prevents collagen degradation, highlighting a biomechanical defense mechanism.

SourceNorth Carolina State University·JournalJournal of Biomechanical Engineering·TypeExperimental study·DateOct 14, 2026

Modifying heart cell metabolism unlocks self-repair system after heart attack

Researchers at Sanford Burnham Prebys discovered that blocking an energy transfer enzyme shifts mammalian hearts into a regenerative state, promoting regeneration and improving recovery after a heart attack. By modulating heart cell metabolism, scientists can potentially awaken the heart's dormant regenerative abilities.

SourceSanford Burnham Prebys·JournalNature Cardiovascular Research·TypeExperimental study·DateSep 28, 2026

Even low levels of nighttime light exposure may weaken the heart, increase the risk of cardiovascular disease

Even low levels of nighttime light exposure can lead to structural changes in the heart, increasing the risk of cardiovascular disease. Researchers analyzed data from 11,017 participants and found that those exposed to higher levels of light saw a thickening of the heart's walls and reduced flexibility during a heartbeat.

SourceTulane University·JournalEuropean Heart Journal·TypeObservational study·DateSep 9, 2026

Mental health conditions after trauma linked to higher cardiovascular risk

Research suggests that mental health conditions, including PTSD, substance abuse, and depression, can increase the risk of future cardiovascular risks such as heart attacks, strokes, and cardiovascular death. Alcohol abuse was found to be the top psychiatric predictor of serious heart and brain conditions for both men and women.

SourceAmerican Heart Association·JournalJournal of the American Heart Association·DateSep 2, 2026

Molecular mapping reveals hidden cellular programs in heart transplant rejection

Researchers at Vanderbilt University Medical Center used spatial transcriptomics to characterize acute rejection and response to immunomodulatory therapies following heart transplantation. The study linked cell-specific gene expression patterns to the development of cardiac allograft vasculopathy, a form of chronic rejection that limit...

SourceVanderbilt University Medical Center·JournalNature Cardiovascular Research·TypeImaging analysis·DateAug 10, 2026

Mini monitor measures artificial heartbeat

A new device inspired by fish's lateral line senses the pulse of lab-grown heart tissue, enabling real-time monitoring of hundreds of tests. This breakthrough could revolutionize drug screening and personalized medicine with more accurate human tissue simulations.

SourceUniversity of Tokyo·TypeExperimental study·DateJun 28, 2026

Better heart 'digital twins' could help target treatment for Atrial Fibrillation (erratic heartbeat)

Researchers at Queen Mary University of London developed digital models of individual patients' hearts to simulate Atrial Fibrillation behavior. Combining three types of data, including MRI scans and electrical voltage measurements, identified more targets than imaging alone.

SourceQueen Mary University of London·JournalThe Journal of Physiology·TypeComputational simulation/modeling·DateJun 17, 2026

Changes to the heart linked to marathon running vary by age, sex, and training level

Research synthesis reveals consistent biomarker increases and minor ventricular function changes after marathon running, varying by age, sex, and training level. However, the clinical relevance of these changes remains unclear, warranting further study to determine physiological responses versus long-term adaptations.

SourceBMJ Group·JournalBMJ Open Sport & Exercise Medicine·TypeMeta-analysis·DateJun 9, 2026

Scientists uncover protein that could help failing hearts

Researchers identified a key protein called PERM1 that is restored in patients whose hearts recover after left ventricular assist device (LVAD) support. PERM1 regulates energy production and contractile function in heart cells, and its normalization is associated with improved cardiac function.

SourceVirginia Tech·JournalJournal of the American Heart Association·TypeExperimental study·DateMay 21, 2026

Global collaboration on Kawasaki disease key to reducing risk of serious heart conditions

A new science advisory calls for coordinated international efforts to reduce disparities in care for children with Kawasaki disease, a rare but serious illness primarily affecting young children. The advisory highlights the importance of sharing data, expertise, and best practices to improve heart health outcomes for children with Kawa...

SourceAmerican Heart Association·JournalJournal of the American Heart Association·DateMay 18, 2026

Microaxial flow pump does not improve outcomes for high-risk heart attack patients without cardiogenic shock

A new trial found that using a microaxial flow pump before and during cardiac stenting procedures for high-risk heart attack patients with severe heart attacks did not reduce heart damage. The study, published in the Journal of the American College of Cardiology, also showed increased bleeding complications.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalJournal of the American College of Cardiology·TypeRandomized controlled/clinical trial·DateMar 28, 2026

Korea University study identifies liver–metabolic disease as a key risk factor for heart failure in older adults with atrial fibrillation

A Korea University study reveals that liver metabolic disease is a key risk factor for heart failure in older adults with atrial fibrillation, with MASLD having the lowest risk and ALD carrying the highest risk. The study highlights the importance of liver health in cardiovascular disease management.

SourceKorea University College of Medicine·JournalEuropean Journal of Heart Failure·TypeObservational study·DateMar 23, 2026